This week’s EU health policy developments span youth mental health, medical device and chemical regulation, and environmental health — with new Commission answers on Lyme diagnostics, ethanol classification, and EU-US tariff exemptions for pharmaceuticals.
This week’s EU health and policy developments range from vaccine liability, disease preparedness, and women’s health to food additives, medical device reform, and healthcare funding. The Commission reaffirmed its commitments on vaccine safety, climate resilience, data protection, and equitable access to medicines and care across Member States.
